A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for ...

Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

The researchers concluded that slower turnaround time for biomarker testing is associated with early non-targeted treatment in patients with ALK +/ EGFR + advanced NSCLC, a practice that is “common,” ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...

Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Cancer Stem Cell Market Cancer stem cells (CSCs) are a distinct subset of tumor cells with stem-like properties, including self-renewal and ...

Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part ...

Discover the growth rates of 5 different skin cancers, from slow-developing basal cell carcinomas to aggressive melanomas, ...

The following is a summary of "Novel devices and biomarkers in screening for esophageal squamous cell cancer," published in ...